Venous distensibility may be an indicator of early arteriovenous fistula failure, a retrospective single-centre cohort study.


Journal

Renal failure
ISSN: 1525-6049
Titre abrégé: Ren Fail
Pays: England
ID NLM: 8701128

Informations de publication

Date de publication:
Dec 2024
Historique:
medline: 31 10 2024
pubmed: 31 10 2024
entrez: 30 10 2024
Statut: ppublish

Résumé

Arteriovenous-fistula (AVF) are crucial for hemodialysis access, yet they frequently experience early failure. While studies have identified potential patient and clinical risk factors, these findings remain inconsistent. This inconsistency might be attributed to the varying definitions of "early failure". Our retrospective cohort study aimed to evaluate how common risk factors predict four frequently early-failure criteria: thrombosis/stenosis, <500 ml/min blood flow, <5 mm vein diameter, and ≥6 mm deep vein. We also assessed how well these risk factors predict early failure defined as meeting at least one of these criteria. Additionally, we examined the predictive ability of vein-distensibility, a previously overlooked factor in AVF failure. Consecutive patients with first-time AVF employing standard minimum preoperative artery- and vein-diameters (1.8-2.0 mm) who underwent first Doppler-ultrasound (DUS) at ≤4 months in 2016-2022 were identified. Early AVF failure was defined as the presence of at least one of the following conditions on the first DUS: poor blood flow (Qa), poor vein diameter, poor vein depth, and thrombosis/stenosis. Factors associated with early AVF failure were explored with multivariate analyses. 105 patients were eligible and 63 (60%) had an early AVF failure. The only strong predictor of early failure was low vein-distensibility (Odds ratio = 0.57, 95% confidence intervals [CIs] = 0.38-0.83, venous distensibility may be a useful early-failure determinant when minimum preoperative vessel-diameter limits are met. Moreover, the female sex is associated with too-deep AVF veins.

Sections du résumé

BACKGROUND UNASSIGNED
Arteriovenous-fistula (AVF) are crucial for hemodialysis access, yet they frequently experience early failure. While studies have identified potential patient and clinical risk factors, these findings remain inconsistent. This inconsistency might be attributed to the varying definitions of "early failure". Our retrospective cohort study aimed to evaluate how common risk factors predict four frequently early-failure criteria: thrombosis/stenosis, <500 ml/min blood flow, <5 mm vein diameter, and ≥6 mm deep vein. We also assessed how well these risk factors predict early failure defined as meeting at least one of these criteria. Additionally, we examined the predictive ability of vein-distensibility, a previously overlooked factor in AVF failure.
METHODS UNASSIGNED
Consecutive patients with first-time AVF employing standard minimum preoperative artery- and vein-diameters (1.8-2.0 mm) who underwent first Doppler-ultrasound (DUS) at ≤4 months in 2016-2022 were identified. Early AVF failure was defined as the presence of at least one of the following conditions on the first DUS: poor blood flow (Qa), poor vein diameter, poor vein depth, and thrombosis/stenosis. Factors associated with early AVF failure were explored with multivariate analyses.
RESULTS UNASSIGNED
105 patients were eligible and 63 (60%) had an early AVF failure. The only strong predictor of early failure was low vein-distensibility (Odds ratio = 0.57, 95% confidence intervals [CIs] = 0.38-0.83,
CONCLUSIONS UNASSIGNED
venous distensibility may be a useful early-failure determinant when minimum preoperative vessel-diameter limits are met. Moreover, the female sex is associated with too-deep AVF veins.

Identifiants

pubmed: 39476866
doi: 10.1080/0886022X.2024.2420829
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2420829

Auteurs

Zead Tubail (Z)

Department of Nephrology-Hemodialysis and Therapeutic Apheresis, Metz-Thionville Regional Hospital Center, Mercy Hospital, Metz, France.

Vincent Dinot (V)

Clinical Research Support Unit, Metz-Thionville Regional Hospital Center, Mercy Hospital, Metz, France.

Christophe Goetz (C)

Clinical Research Support Unit, Metz-Thionville Regional Hospital Center, Mercy Hospital, Metz, France.

Benjamin Savenkoff (B)

Department of Nephrology-Hemodialysis and Therapeutic Apheresis, Metz-Thionville Regional Hospital Center, Mercy Hospital, Metz, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH